Are you Dr. Lightbourne?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 19 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
50 E Canfield St
Detroit, MI 48201Phone+1 313-745-6960Fax+1 313-966-7305
Summary
- Dr. Marissa Lightbourne, MD is a pediatric endocrinologist in Detroit, Michigan. She is currently licensed to practice medicine in Michigan and District of Columbia.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine/Pediatrics, 2010 - 2014
University of Minnesota Medical SchoolClass of 2010
Certifications & Licensure
DC State Medical License 2015 - 2024
MI State Medical License 2014 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- Effects of Metreleptin in Patients with Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease.Maiah Brush, Sungyoung Auh, Elaine Cochran, Rebecca Tuska, Christopher Koh
The Journal of Clinical Endocrinology and Metabolism. 2024-05-17 - 5 citationsInsulin Signaling Through the Insulin Receptor Increases Linear Growth Through Effects on Bone and the GH-IGF-1 Axis.Marinna C Okawa, Rebecca M Tuska, Marissa Lightbourne, Brent S Abel, Mary Walter
The Journal of Clinical Endocrinology and Metabolism. 2023-12-21 - 7 citationsVolanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy.Marissa Lightbourne, Megan Startzell, Kimberley D Bruce, Brianna Brite, Ranganath Muniyappa
Journal of Clinical Lipidology. 2022-09-22
